Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Am J Ophthalmol. 2023 Feb 21;252:213–224. doi: 10.1016/j.ajo.2023.02.013

Figure 4: Comparison of Optic Neuritis Treatment Trial vs Plasma exchange.

Figure 4:

The chance of final outcome of 20/40 or better is compared across different matched time points between the Optic Neuritis Treatment Trial (ONTT) (blue solid line) and the Plasma exchange (PLEX) (red dashed line) cohorts among eyes that were 20/200 or worse with minimal response to intravenous methylprednisolone (IVMP). * indicates a statistically significant difference.